ARRY
Array Biopharma Inc
ARRY
ARRY
Delisted
ARRY was delisted on the 29th of July, 2019.
128 hedge funds and large institutions have $445M invested in Array Biopharma Inc in 2016 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 38 increasing their positions, 43 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
12% less repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 43
18% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 17
Holders
128
Holding in Top 10
3
Calls
$3.25M
Puts
$2.55M
Top Buyers
| 1 | +$6.33M | |
| 2 | +$5.07M | |
| 3 | +$2.35M | |
| 4 |
CEP
Chicago Equity Partners
Chicago,
Illinois
|
+$1.94M |
| 5 |
NC
Nexthera Capital
New York
|
+$1.85M |
Top Sellers
| 1 | -$7.59M | |
| 2 | -$5.9M | |
| 3 | -$4.5M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$4.45M |
| 5 |
DM
Deerfield Management
New York
|
-$4.16M |